🎉 M&A multiples are live!
Check it out!

IBA Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for IBA Group and similar public comparables like Philips, InfuSystem, and Myomo.

IBA Group Overview

About IBA Group

Ion Beam Applications SA develops and manufactures medical devices and software solutions. The firm operates in two segments: proton therapy and other accelerators and dosimetry. Proton therapy and other accelerators business contribute to the majority of sales. It offers solutions for precision cancer treatment through the use of proton beams, as well as cyclotrons used for the production of radioisotopes and industrial accelerators for sterilization and ionization. The dosimetry business sells measurement and quality assurance instruments for radiotherapy and medical imaging. The firm operates in three geographical areas: Belgium, the United States, and the Rest of the World.


Founded

1986

HQ

Belgium
Employees

2.1K+

Financials

LTM Revenue $666M

LTM EBITDA $45.7M

EV

$422M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

IBA Group Financials

As of September 2025, IBA Group reported last 12-month revenue of $666M and EBITDA of $45.7M.

In the same period, IBA Group generated $282M in LTM gross profit and $16.8M in net income.

See IBA Group valuation multiples based on analyst estimates

IBA Group P&L

In the most recent fiscal year, IBA Group reported revenue of $576M and EBITDA of $33.3M.

IBA Group expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See IBA Group valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $666M XXX $576M XXX XXX XXX
Gross Profit $282M XXX $192M XXX XXX XXX
Gross Margin 42% XXX 33% XXX XXX XXX
EBITDA $45.7M XXX $33.3M XXX XXX XXX
EBITDA Margin 7% XXX 6% XXX XXX XXX
EBIT $30.6M XXX $11.4M XXX XXX XXX
EBIT Margin 5% XXX 2% XXX XXX XXX
Net Profit $16.8M XXX $10.7M XXX XXX XXX
Net Margin 3% XXX 2% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

IBA Group Stock Performance

IBA Group has current market cap of EUR 335M (or $387M), and EV of EUR 365M (or $422M).

Market Cap Evolution

IBA Group Stock Data

As of October 17, 2025, IBA Group's stock price is EUR 11 (or $13).

See IBA Group trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$422M $387M XXX XXX XXX XXX $0.56

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

IBA Group Valuation Multiples

IBA Group's trades at 0.7x EV/Revenue multiple, and 12.7x EV/EBITDA.

See valuation multiples for IBA Group and 15K+ public comps

IBA Group Financial Valuation Multiples

As of October 17, 2025, IBA Group has market cap of $387M and EV of $422M.

Equity research analysts estimate IBA Group's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

IBA Group has a P/E ratio of 23.0x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $387M XXX $387M XXX XXX XXX
EV (current) $422M XXX $422M XXX XXX XXX
EV/Revenue 0.6x XXX 0.7x XXX XXX XXX
EV/EBITDA 9.2x XXX 12.7x XXX XXX XXX
EV/EBIT 13.8x XXX 36.9x XXX XXX XXX
EV/Gross Profit 1.5x XXX n/a XXX XXX XXX
P/E 23.0x XXX 36.2x XXX XXX XXX
EV/FCF -7.5x XXX -20.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get IBA Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

IBA Group Margins & Growth Rates

IBA Group's last 12 month revenue growth is 6%

IBA Group's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

IBA Group's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

IBA Group's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for IBA Group and other 15K+ public comps

IBA Group Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 6% XXX 11% XXX XXX XXX
EBITDA Margin 7% XXX 6% XXX XXX XXX
EBITDA Growth 27% XXX 82% XXX XXX XXX
Rule of 40 9% XXX 12% XXX XXX XXX
Bessemer Rule of X XXX XXX 22% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $0.1M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 6% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX 12% XXX XXX XXX
Opex to Revenue XXX XXX 31% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

IBA Group Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

IBA Group M&A and Investment Activity

IBA Group acquired  XXX companies to date.

Last acquisition by IBA Group was  XXXXXXXX, XXXXX XXXXX XXXXXX . IBA Group acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by IBA Group

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About IBA Group

When was IBA Group founded? IBA Group was founded in 1986.
Where is IBA Group headquartered? IBA Group is headquartered in Belgium.
How many employees does IBA Group have? As of today, IBA Group has 2.1K+ employees.
Who is the CEO of IBA Group? IBA Group's CEO is Mr. Olivier Legrain.
Is IBA Group publicy listed? Yes, IBA Group is a public company listed on BRU.
What is the stock symbol of IBA Group? IBA Group trades under IBAB ticker.
When did IBA Group go public? IBA Group went public in 1998.
Who are competitors of IBA Group? Similar companies to IBA Group include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of IBA Group? IBA Group's current market cap is $387M
What is the current revenue of IBA Group? IBA Group's last 12 months revenue is $666M.
What is the current revenue growth of IBA Group? IBA Group revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of IBA Group? Current revenue multiple of IBA Group is 0.6x.
Is IBA Group profitable? Yes, IBA Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of IBA Group? IBA Group's last 12 months EBITDA is $45.7M.
What is IBA Group's EBITDA margin? IBA Group's last 12 months EBITDA margin is 7%.
What is the current EV/EBITDA multiple of IBA Group? Current EBITDA multiple of IBA Group is 9.2x.
What is the current FCF of IBA Group? IBA Group's last 12 months FCF is -$56.3M.
What is IBA Group's FCF margin? IBA Group's last 12 months FCF margin is -8%.
What is the current EV/FCF multiple of IBA Group? Current FCF multiple of IBA Group is -7.5x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.